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Abstract: 
 
Background: Shared decision making (SDM) is frequently advocated but not yet widely 
implemented in European countries. Experience suggests that various incentives must be in 
alignment to encourage wider uptake.  
Objectives: To assess readiness for mainstream implementation of SDM in five European 
countries. 
Methods: Qualitative assessment of clinical policies and the availability of various SDM 
support services in Germany, France, Spain, the Netherlands and the UK. 
Results: All five countries have research groups working on SDM, patient groups calling for 
its wider use, and ethical and professional standards indicating its desirability, but apart from 
a small number of demonstration projects, there is no evidence of a systematic approach to 
implementation in any of the countries as yet.  
Conclusions: Greater attention will need to be given to the provision of effective leadership, 
training and practical support if SDM is to become a regular feature of clinical practice in 
these countries. 
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Background 
Shared decision making (SDM) is a process in which clinicians and patients work together to select 
tests, treatments, management or support packages, based on clinical evidence and the patient’s 
informed preferences. It involves the provision of evidence-based information about options, 
outcomes and uncertainties, together with decision support counselling and a systematic approach 
to recording and implementing patient’s preferences (1). This has been shown to improve patients’ 
knowledge and ability to participate in decisions about their care, improving the quality of clinical 
decision-making (2). It also leads to improvements in health outcomes for people with long-term 
health problems (3). It is appropriate for patients facing major healthcare decisions where there is 
more than one feasible and evidence-based option, for decisions about screening tests and 
preventive strategies, and for choosing care and support packages for long-term conditions (4). 
SDM has been enthusiastically embraced by patient groups, policy makers, clinicians, researchers 
and professional societies in several European countries, but it has been slow to filter into 
mainstream clinical practice (5). Successful implementation depends on aligning incentives for both 
clinicians and patients, providing training and support, and ensuring that patient information and 
decision aids are readily accessible via electronic systems to avoid disruption to clinical  routines (6).  
Experience in various demonstration projects in the US 
(http://www.informedmedicaldecisions.org/shared-decision-making-in-practice/demonstration-
sites/) and Europe  (http://www.health.org.uk/areas-of-work/topics/person-centred-care/) leads us 
to believe that the following ten factors need to be in place to promote more widespread adoption: 
1. Research evidence showing that it can be effective in a specific clinical or local context 
2. Medical leadership willing to encourage it 
3. Demand for it from patient leaders and organisations 
4. Incentives for clinicians to change their practice – ethical, financial, or professional 
5. Training for clinical staff in SDM and risk communication skills, plus support and supervision 
for implementation 
6. Availability of good quality patient decision aids (PtDAs) 
7. Integration of PtDAs into electronic medical record systems 
8. Institutional support for developing and updating PtDAs 
9. Certification schemes to assure the quality of PtDAs 
10. Validated measures to monitor the extent to which patients feel informed and involved in 
decisions about their care, plus feedback to enable clinicians to monitor progress. 
Recent developments in the USA have pushed SDM higher up the policy agenda (7), but it is not 
clear if the same is happening in Europe.  Two special issues of the German Journal for Evidence and 
Quality in Health Care in 2007 (8) and 2011 (9) described progress in some European countries in 
respect of researching and implementing SDM, but this is a fast-moving field. We therefore decided 
to compare and assess the situation in five European countries in respect of their readiness for SDM 
in 2015.  
 
Objectives 
To assess the policy climate in respect of SDM in five European countries - France, Germany, the 
Netherlands, Spain and the UK – with reference to ten factors considered necessary for successful 
implementation. 
 
Methods 
The ten factors listed above were used as a checklist against which each author made an 
independent assessment of the situation in his or her country. We based this qualitative assessment 
on our knowledge of SDM policy, research and practice. Our qualifications for making the 
assessments rest on the fact that, as leading academics in this field, we have been researching, 
teaching and writing about SDM for many years. Each of us has specialised knowledge of SDM policy 
in our own country and good general knowledge of international developments.  As advisors and 
active players in SDM implementation initiatives we believe we are well-placed to assess progress 
towards mainstream adoption of SDM in each of the countries.  
The independently produced assessments were collated and tabulated by the lead author (AC). All 
authors contributed to the overview commentary. 
 
Results 
Detailed responses are given in Table 1. Below we provide an overview of progress in these 
European countries in respect of each of the ten factors. 
1. Research evidence: Studies of SDM implementation and the use and effectiveness of PtDAs have 
been carried out in each of the five countries. There is now a large body of published literature 
on the topic and several systematic reviews on SDM effectiveness and implementation, as well 
as methodological reviews (3, 10-13). These studies have demonstrated the relevance of SDM in 
a variety of clinical contexts. 
 
2. Medical leadership: There is no shortage of individual clinical champions of SDM in each of the 
five countries (6). However, the major medical and nursing organisations have been slow to give 
it their whole-hearted support, paying lip service but not yet exerting the full weight of their 
very considerable influence to ensure that SDM is implemented. 
 
3. Patient demand: SDM is supported in patients’ rights legislation and patient charters in several 
countries (14). Many European patient organisations see implementation of SDM as a priority 
(15). Their voice is increasingly heard in local, national and international policy forums, but their 
influence has not yet proved strong enough to prompt a concerted effort to implement SDM 
throughout mainstream clinical practice.  
 
4. Incentives for clinicians: SDM is now seen as an ethical and, increasingly, a legal imperative in 
these countries, backed by professional quality standards and guidelines (16, 17). But there have 
been no attempts as yet in these European countries to use financial incentives to encourage 
clinicians to practise SDM. 
 
5. Training and support: The picture in respect of SDM skills training is patchy. Various short 
courses and workshops have been developed and SDM is beginning to be included in basic 
communication skills training (18). However it is not yet seen as a core component of European 
medical and nursing education, with the possible exception of Germany where it is now taught 
and examined in most medical schools (19). 
 
6. Availability of decision aids: Here again we see a mixed picture. PtDAs are not absolutely 
essential for SDM but, by packaging evidence-based information in an accessible form, they 
certainly make it easier (2). A limited number of decision aids is available in each of the 
countries. National policymakers are now encouraging the production of PtDAs in each of the 
five countries, with most progress to date in the UK, where government funds have supported 
the development of a core set of publicly available decision aids (20). 
 
7. Integration into EMRs: For PtDAs to be widely used they must be readily accessible at 
appropriate decision points. One way to ensure this is to integrate them into electronic medical 
records (EMRs). This has been achieved by one of the four main general practice EMR systems 
accredited for use in the UK http://www.emis-online.com/, but we are unaware of any similar 
primary care initiatives in the other four countries.  Patient decision aids are sometimes included 
in specialty-based electronic systems and several studies are evaluating web-based tools and 
applications for patients. 
 
8. Institutional support: Many PtDAs have been developed as part of individual projects, but 
development is only one part of the story. They need to be hosted in an accessible place or 
website, user-tested, promoted, distributed and kept up-to-date (21). None of the five countries 
has a clear mechanism for doing this at present, though some national bodies, including health 
ministries, are considering the establishment of some form of institutional support for hosting 
and updating. There is some interest in linking this function to that of national clinical guideline 
production under the auspices of organisations such as the Institute for Quality and Efficiency in 
Health Care (IQWiG) in Germany and the National Institute for Health and Care Excellence (NICE) 
in the UK (22). 
 
9. Certification schemes: Effective implementation of SDM depends on trust in the reliability of the 
information, which must also be well-designed and user-tested. The International Patient 
Decision Aids Standards (IPDAS) were developed by an international multi-stakeholder group 
(23, 24) and there is considerable interest in using these as the basis for certification schemes to 
assure the quality of PtDAs. No formal certification schemes have been established to date, but 
discussions are currently under way in each of the five countries. 
 
10. Measurement and feedback: Measuring performance in shared decision making and feeding 
this information back to clinicians is widely agreed to be important for stimulating better 
practice. A number of patient-reported measures have been developed but there is no 
consensus on which, if any, are most appropriate for this purpose (25, 26). Some work has been 
done to translate and test these measures, but no widespread SDM performance monitoring 
scheme has been established in any of the five countries as yet (12, 27). 
 Discussion 
This study was based on our knowledge of policy developments in each of the countries. 
Unfortunately there is no statistical evidence on the penetration of SDM or the wide range of factors 
contributing to its uptake to validate our impressions. It is always possible that our knowledge is 
incomplete, but we believe we are well placed to make informed judgements on the extent to which 
various incentives to practise SDM are in place. In view of our longstanding interest in the topic and 
extensive networks, we think it unlikely that we have missed any significant developments.  
We found evidence of growing interest in SDM in each of the five countries. Academic researchers 
have led the way, with some strong research groups in each of the five countries and significant 
numbers of published papers. Patient groups are calling for SDM and many clinicians, health 
insurance companies and policymakers are very interested. Some guideline groups and professional 
bodies are promoting SDM, but there is a lack of strong, effective push from professional 
associations at present. SDM skills training is not yet widespread across Europe. 
Some PtDAs have been developed and tested with local patients in each of the countries, but many 
of these were developed for research purposes only with no institutional support or plan for wide 
dissemination. It is still rare for PtDAs to be incorporated into electronic medical record systems and 
there are no certification procedures in place. Patient questionnaires to measure whether SDM has 
occurred are under development, but we found no examples of coordinated performance 
measurement. None of the five countries has adopted a systematic national or regional approach to 
SDM implementation as yet. 
 
Conclusions 
Successful implementation of SDM in Europe will require wider provision of training, support and 
supervision, and greater availability of PtDAs, ideally integrated into EMRs so they are readily 
available when needed. There will also need to be organisations capable of developing these and 
keeping them up-to-date, perhaps linked to the production of clinical guidelines, and certification 
schemes to quality assure them. Above all, attention needs to be paid to means of incentivising 
clinicians to change the way they practise so as to engage patients more actively in decisions about 
their care. The adoption of appropriate performance and outcome measures could play a key role in 
focusing attention on what needs to change. 
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Table 1: Assessment of current situation in five European countries 
 France Germany Netherlands Spain UK 
Research 
evidence 
A number of SDM 
studies have been 
carried out in 
France since the 
mid 1990s, mainly 
in cancer care.  
Research 
consortium (2001-
7) funded by the 
Federal Ministry of 
Health with 10 
SDM 
demonstration 
projects; large 
number of projects 
funded by the 
Federal Ministry of 
Education and 
Research, health 
insurance 
companies,  
German Pension 
Fund, German 
Cancer Aid, 
Bertelsmann and 
other foundations 
(since 2008).  
A number of 
studies in oncology 
and evaluation of 
patient decision 
aids have been 
conducted in the 
Netherlands. There 
has been less focus 
on changing 
professional 
behaviour and 
implementing SDM 
in mainstream 
practice.  
Studies of SDM in 
cancer care, mental 
health 
osteoarthritis, 
diabetes, primary 
care and some rare 
diseases have been 
carried out, 
including 
development and 
evaluation of 
decision aids, 
measurement and 
implementation 
issues.  
Research into SDM 
started in the early 
1990s in the UK 
and numerous 
studies have been 
published since 
then. 
Medical 
leadership 
Medical leaders in 
oncology (breast 
cancer) have been 
promoting SDM for 
at least two years, 
and this has 
occurred more 
recently in 
psychiatry, primary 
care, 
rheumatology, 
asthma, and 
addiction. 
SDM is 
championed by 
oncologists, GPs, 
psychiatrists, 
neurologists, 
psychologists, 
medical 
sociologists and 
nurses. It is also 
promoted by the 
German Network 
of Evidence-Based 
Medicine, and the 
German Agency for 
Quality in Medicine 
among others. 
Some medical 
opinion leaders are 
promoting SDM. 
SDM is promoted 
by medical and 
nursing leaders in 
cancer care, 
psychiatry, 
endocrinology, 
trauma care and 
primary care. 
Several medical 
royal colleges are 
promoting the 
concept, notably 
Royal College of 
GPs, Royal College 
of Physicians, Royal 
College of 
Psychiatrists and 
Royal College of 
Surgeons.  
Patient 
demand 
Patient demand led 
to the Patients’ 
Rights and Quality 
of the Healthcare 
system Law 
adopted in France 
in March 2002. 
SDM is mentioned 
in one article of 
this law 
(Art.L.1111-4). 
SDM is supported 
by patient 
associations in 
cancer and kidney 
care. 
Many self-help 
organisations are 
demanding SDM on 
a continuous basis. 
Specific pressure 
comes from the 
accredited 
members of self-
help organizations 
within the Federal 
Committee, the 
principal institution 
responsible for 
health care 
reimbursement 
decisions 
The Dutch Patient 
and Consumer 
Federation is 
running a 
demonstration 
project 
implementing the 
Ask 3 Questions 
campaign in three 
sites, funded by the 
Ministry of Health. 
SDM is a priority 
for the Spanish 
Patient’s Forum 
and for some other 
patients’ 
associations 
including GEPAC 
and FEDER. Called 
for in some 
national and 
international 
declarations by 
patient 
organisations. 
SDM is a priority 
for National Voices, 
the leading 
umbrella group for 
patient 
organisations in 
England (with 140 
members), and for 
similar 
organisations in 
Scotland, Wales 
and Northern 
Ireland. It is also a 
commitment 
within the NHS 
Constitution, a 
charter for patients 
and staff. 
Incentives for 
clinicians 
The importance of 
patient partnership 
is understood by 
many clinicians as a 
key component of 
quality care. No 
direct financial or 
professional 
incentives are in 
place, but SDM is 
recommended in 
Most professionals 
understand that 
SDM is an ethical 
imperative, but no 
direct incentives 
are provided. 
However, SDM is 
encouraged in 
several national 
clinical guidelines. 
The “2014 patient’s 
SDM is encouraged 
in several national 
clinical guidelines, 
with the first 
guideline just 
launched (on 
hernia nucleus 
pulposis 
management) with 
a patient decision 
aid directly 
Most professionals 
understand that 
SDM is an ethical 
imperative, but 
there are no direct 
financial or 
professional 
incentives to 
practise it, apart 
from the fact that 
SDM is 
SDM is embedded 
in the Good 
Medical Practice 
standards 
published by the 
General Medical 
Council, the main 
professional 
regulator. A recent 
legal judgement 
has clarified and 
some cancer 
clinical guidelines. 
rights law” includes 
a commitment to  
SDM in clinical 
encounters.  
integrated in the 
guideline. There 
are no direct 
financial or 
professional  
incentives to 
implement SDM. 
recommended in 
some clinical 
guidelines. 
strengthened the 
law vis a vis SDM. 
There are no direct 
financial incentives, 
but SDM is 
recommended in 
several clinical 
guidelines.  
Training and 
support 
Training is seen as 
a priority but not 
yet developed.  
FREeDOM (an 
international 
French-speaking 
multidisciplinary 
working group on 
SDM) is planning 
training projects. 
SDM is taught in 
most medical 
schools and is part 
of the pre-clinical 
exam. Some 
medical schools 
use OSCEs to test 
students on 
practical SDM skills. 
Some training 
courses have been 
developed and 
tested for 
specialists (GPs, 
oncologists). 
SDM skills training 
is available on a 
small scale as a bi-
product of research 
projects, and some 
academic faculties 
have (elective) 
educational 
modules on SDM in 
undergraduate of 
postgraduate 
courses . 
SDM skills are 
included as a 
component of 
some specialist 
training 
programmes + 
many conferences, 
seminars and short 
courses. It is now a 
priority to develop 
and assess the 
effectiveness of 
SDM skills training 
programmes. 
SDM is increasingly 
included in 
communications 
training for medical 
students. A variety 
of short training 
courses are 
provided for 
various 
professional 
groups.  
Availability of 
decision aids 
The National 
Health Insurance 
Fund (CNAMTS) 
and the National 
Heath Authority 
have both called 
for PtDAs to be 
developed. 
FREeDOM (see 
above) has 
highlighted PtDA 
development as 
their second most 
important priority. 
About 10 – 15 
PtDAs are available 
for topics such as 
mammography, 
breast cancer, 
prostate cancer 
screening, HPV 
vaccination, mental 
health. Some 
Option Grids (brief 
decision aids) are in 
translation and are 
being tested.  
The Dutch Ministry 
of Health has 
launched a call for 
proposals to 
develop and host  
PtDAs. 
Web-based 
information 
materials are 
available, e.g. 
PyDeSalud.com for 
people with 
chronic conditions, 
which includes 
PtDAs. 
There is public 
access to 36 ‘Right 
Care’ decision aids 
funded by the 
Department of 
Health, + 18 Option 
Grids developed by 
Cardiff University, 
and 10 Brief 
Decision Aids 
developed at 
Newcastle 
University. 
Integration 
into EMRs 
No No No but planned as 
a component of 
specific EMR 
quality assurance 
projects. 
No, but planned as 
a component of 
specific research 
projects. 
Yes, via the EMIS 
general practice 
clinical record 
system 
(patient.co.uk). 
Institutional 
support 
No, but discussions 
have taken place 
with the French 
National Cancer 
Institute to plan 
the development 
of a suite of PtDAs 
for cancer care and 
prevention. Some 
SDM projects may 
be developed in 
the near future, 
funded by the 
Ministry of Health 
(a call for proposals 
is currently under 
discussion). 
University and 
health insurance 
companies provide 
some support at 
present, but the 
Institute for Quality 
and Efficiency in 
Health Care 
(IQWiG) will 
probably take more 
responsibility for 
the development 
of PtDAs in the 
future. 
Not yet but may 
emerge from a 
Ministry of Health 
initiative. 
The Spanish 
Ministry of Health 
and other funders 
(e.g. a bank and 
health insurance 
companies) are 
supporting some 
initiatives, but no 
single institution is 
responsible for 
developing and 
updating PtDAs. 
NHS England 
provides limited 
support for hosting 
and updating. The 
Health Foundation 
has supported 
various 
demonstration 
projects as part of 
its MAGIC (Making 
Good Decisions in 
Collaboration) 
programme. 
Certification 
schemes 
No formal 
certification 
scheme, but some 
discussions re using 
the IPDAS criteria 
No formal 
certification 
scheme but IPDAS 
is used together 
with ‘Good Practice 
for Health 
Information’ guide 
produced by 
German Network 
for Evidence-Based 
Medicine together 
with IQWiG 
No formal 
certification 
scheme, but 
Ministry of Health 
has issued a call for 
proposals to 
develop a Dutch 
version of IPDAS, 
together with a 
guide on how to 
develop PtDAs 
No formal 
certification 
scheme, but 
Spanish Ministry of 
Health is 
interested. A 
Spanish version of 
the IPDAS 
standards is in use 
in some regions. 
NHS England runs a 
certification 
scheme for patient 
information (The 
Information 
Standard). They 
have been in 
discussion with the 
National Institute 
for Health and Care 
Excellence (NICE) 
about developing a 
specific scheme for 
PtDAs based on the 
IPDAS criteria.  
Measurement 
and feedback 
Discussions only at 
this stage. 
Measurement tools 
are being 
developed and 
tested, including 
German 
adaptations of 
international 
instruments 
Work is under way 
to develop and 
validate Dutch 
versions of SDM-Q-
9, CollaboRATE and 
OPTION-5 
instruments 
Work is under way 
but better 
measures are 
needed. 
NHS England 
commissioned and 
published an 
overview of 
validated measures 
but none has yet 
been adopted for 
national use. 
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